Exact Sciences (EXAS) Receivables - Other (2023 - 2025)
Exact Sciences (EXAS) has disclosed Receivables - Other for 3 consecutive years, with $31.8 million as the latest value for Q3 2025.
- On a quarterly basis, Receivables - Other rose 23.26% to $31.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $31.8 million, a 23.26% increase, with the full-year FY2024 number at $25.9 million, down 37.89% from a year prior.
- Receivables - Other was $31.8 million for Q3 2025 at Exact Sciences, down from $32.7 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $68.9 million in Q3 2023 to a low of $25.8 million in Q3 2024.
- A 3-year average of $38.1 million and a median of $32.7 million in 2025 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: plummeted 62.55% in 2024, then increased 23.26% in 2025.
- Exact Sciences' Receivables - Other stood at $41.7 million in 2023, then crashed by 37.89% to $25.9 million in 2024, then rose by 22.78% to $31.8 million in 2025.
- Per Business Quant, the three most recent readings for EXAS's Receivables - Other are $31.8 million (Q3 2025), $32.7 million (Q2 2025), and $29.9 million (Q1 2025).